10x Genomics, Inc. vs Simulations Plus, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- 10x Genomics, Inc. is the larger company by market value: $9.4 B against $371 M for Simulations Plus, Inc., 25 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- 10x Genomics, Inc. had more revenue: $643 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025.
- Both made a net loss: $44 M for 10x Genomics, Inc. and $65 M for Simulations Plus, Inc.
- 10x Genomics, Inc. keeps more of each dollar of sales: a net margin of -6.8% against -81.7% for Simulations Plus, Inc.
- Simulations Plus, Inc.'s revenue grew faster in its latest fiscal year: +13.1% against +5.2% for 10x Genomics, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | 10x Genomics, Inc. TXG · #2,271 in the world | Simulations Plus, Inc. SLP |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2012 | 1996 |
| Size | ||
| Market cap | $9.4 B | $371 M* |
| Revenue | $643 M | $79 M |
| Net income | $-44 M▲ best | $-65 M |
| Employees | 1,243 | — |
| Valuation | ||
| Price to sales | 15.2× | — |
| Price to book | 11.8× | — |
| Free cash flow yield | 1.4% | — |
| Profitability | ||
| Gross margin | 69.0%▲ best | 58.4% |
| Operating margin | -9.5%▲ best | -89.3% |
| Net margin | -6.8%▲ best | -81.7% |
| Return on equity | -5.8%▲ best | -42.1% |
| Growth | ||
| Revenue growth | 5.3% | 13.1%▲ best |
| Revenue growth, 3 years a year | 7.6% | 13.7%▲ best |
| Cash | ||
| Free cash flow margin | 20.2% | 22.0%▲ best |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, 10x Genomics, Inc. or Simulations Plus, Inc.?
10x Genomics, Inc. is the larger company by market value: $9.4 B against $371 M for Simulations Plus, Inc., 25 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, 10x Genomics, Inc. or Simulations Plus, Inc.?
10x Genomics, Inc. had more revenue: $643 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025. Both made a net loss: $44 M for 10x Genomics, Inc. and $65 M for Simulations Plus, Inc.
Which is more profitable, 10x Genomics, Inc. or Simulations Plus, Inc.?
10x Genomics, Inc. keeps more of each dollar of sales: a net margin of -6.8% against -81.7% for Simulations Plus, Inc.
Which is growing faster, 10x Genomics, Inc. or Simulations Plus, Inc.?
Simulations Plus, Inc.'s revenue grew faster in its latest fiscal year: +13.1% against +5.2% for 10x Genomics, Inc.
More about 10x Genomics, Inc.
More about Simulations Plus, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.